These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. EORTC Group Study 30851: a phase II study of neoadjuvant chemotherapy in patients with invasive bladder cancer. Splinter TA; Jacqmin D; Roberts JT; Pavone-Macaluso M; de Pauw M; Sylvester R; Carpentier P Prog Clin Biol Res; 1990; 353():213-7. PubMed ID: 2217421 [No Abstract] [Full Text] [Related]
7. Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies. Ruggeri EM; Giannarelli D; Bria E; Carlini P; Felici A; Nelli F; Gallucci M; Cognetti F; Pollera CF Cancer; 2006 Feb; 106(4):783-8. PubMed ID: 16419069 [TBL] [Abstract][Full Text] [Related]
8. Current status of bladder cancer protocols in the EORTC Genito-Urinary Group. Denis L; Pavone-Macaluso M; De Pauw M Prog Clin Biol Res; 1984; 162B():429-39. PubMed ID: 6390450 [TBL] [Abstract][Full Text] [Related]
9. [Intra-arterial chemotherapy of patients in the late stages of bladder cancer]. Dunchik VN; Drozdovskiĭ BIa; Kariakin OB; Grishin GN Urol Nefrol (Mosk); 1985; (2):19-23. PubMed ID: 3992752 [No Abstract] [Full Text] [Related]
10. The role of neoadjuvant chemotherapy for invasive bladder cancer. Martínez-Piñeiro JA; Martínez-Piñeiro L Br J Urol; 1998 Jul; 82(1):33-42. PubMed ID: 9698660 [No Abstract] [Full Text] [Related]
18. Management of disseminated disease in the patient with bladder cancer. Perry JJ; Muss HB Urol Clin North Am; 1994 Nov; 21(4):661-72. PubMed ID: 7974898 [TBL] [Abstract][Full Text] [Related]